Tetrahydrofuran → (3-[2-[2-Amino-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl]-3-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-1H-pyrazol-1-yl)acetonitrile
Reaction equation
CC(C)([O-])C.[K+].C1COCC1.[CH3:12][N:13]1[CH2:18][CH2:17][N:16]([C:19]2[CH:24]=[C:23]([N:25]3[CH:34]([CH3:35])[CH2:33][C:32]4[C:27](=[CH:28][C:29]([C:36]5[CH:40]=[CH:39][NH:38][N:37]=5)=[CH:30][CH:31]=4)[CH2:26]3)[N:22]=[C:21]([NH2:41])[N:20]=2)[CH2:15][CH2:14]1.Br[CH2:43][C:44]#[N:45]>CN(C=O)C>[NH2:41][C:21]1[N:22]=[C:23]([N:25]2[CH:34]([CH3:35])[CH2:33][C:32]3[C:27](=[CH:28][C:29]([C:36]4[CH:40]=[CH:39][N:38]([CH2:43][C:44]#[N:45])[N:37]=4)=[CH:30][CH:31]=3)[CH2:26]2)[CH:24]=[C:19]([N:16]2[CH2:15][CH2:14][N:13]([CH3:12])[CH2:18][CH2:17]2)[N:20]=1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
Potassium tert-butoxide in THF (1.0 M, 74.2 uL, 0.0742 mmol) was added to a solution of 4-(4-methylpiperazin-1-yl)-6-[3-methyl-7-(1H-pyrazol-3-yl)-3,4-dihydroisoquinolin-2(1H)-yl]pyrimidin-2-amine (15.0 mg, 0.0371 mmol) in DMF (0.3 mL) and stirred at r.t. for 10 min, and then bromoacetonitrile (3.71 uL, 0.0556 mmol) was added. The mixture was stirred at r.t. for 1 h. LCMS showed the reaction was complete. The mixture was purified by RP-HPLC (pH=10) to afford the desired product. LCMS (M+H)+: m/z=444.2.
Workup
- stirringThe mixture was stirred at r.t. for 1 h
- customThe mixture was purified by RP-HPLC (pH=10)
Sources & evidence
- ORD record
- ord-b515c075cef14035a65c1141df139791
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08436008B2
Reaction notes
Loading…